Application of turbidity monitoring by combined activated partial thromboplastin time and waveform analysis to characterize heterogeneity of hemophilia plasma response to recombinant factor VIII

被引：0
|
作者：
Leong, L. [1 ]
Ramsey, Ph [1 ]
Sim, D. [1 ]
Patel, C. [1 ]
Murphy, J. E. [1 ]
Laux, V [1 ]
机构：
[1] Bayer HealthCare Pharmaceut, US Innovat Ctr, San Francisco, CA USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：839 / 840
页数：2
相关论文
共 17 条
  • [1] Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEGylated recombinant factor VIII (BAY 94-9027) for hemophilia A
    Gu, J-M
    Ramsey, P.
    Evans, V
    Tang, L.
    Apeler, H.
    Leong, L.
    Murphy, J. E.
    Laux, V
    Myles, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 368 - 369
  • [2] Evaluation of activated partial thromboplastin time coagulation waveform analysis for identification of patients with acquired factor VIII inhibitors
    McGinnis, Eric
    Wong, Steven K. W.
    Smith, Tyler W.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2020, 42 (04) : 411 - 417
  • [3] The activated partial thromboplastin time-clot waveform analysis in hemophilia: Does it help in differentiation?
    Mannan, Khalid Abdul
    Kumar, Narender
    Ahluwalia, Jasmina
    Hans, Chander
    Kler, Anita
    Prakash, Gaurav
    Jain, Richa
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 (02) : 241 - 249
  • [4] The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia a patients with very low levels of factor VIII activity (FVIII:C)
    Shima, M
    Matsumoto, T
    Fukuda, K
    Kubota, Y
    Tanaka, I
    Nishiya, K
    Giles, AR
    Yoshioka, A
    THROMBOSIS AND HAEMOSTASIS, 2002, 87 (03) : 436 - 441
  • [5] Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEGylated recombinant factor VIII (BAY 94-9027) for haemophilia A
    Gu, J-M.
    Ramsey, P.
    Evans, V.
    Tang, L.
    Apeler, H.
    Leong, L.
    Murphy, J. E.
    Laux, V.
    Myles, T.
    HAEMOPHILIA, 2014, 20 (04) : 593 - 600
  • [6] Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time
    Souto, JC
    Almasy, L
    Muñiz-Diaz, E
    Soria, JP
    Borrell, M
    Bayén, L
    Mateo, J
    Madoz, P
    Stone, W
    Blangero, J
    Fontcuberta, J
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (08) : 2024 - 2028
  • [7] Clinical utility of activated partial thromboplastin time clot waveform analysis and thrombin generation test in the evaluation of bleeding phenotype in Hemophilia A
    Dave, Rutvi G.
    Geevar, Tulasi
    Mammen, Joy J.
    Vijayan, Ramya
    Mahasampath, Gowri
    Nair, Sukesh C.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2021, 64 (01) : 117 - 122
  • [8] RECOMBINANT FACTOR VIIA(RFVIIA) INDUCED SHORTENING OF THE ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) OF FACTOR-VIII DEFICIENT PATIENTS - AN INVITRO ARTIFACT
    MACIK, BG
    MONROE, DM
    NEMERSON, Y
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1311 - 1311
  • [9] A clot waveform analysis-based system for differential diagnosis of prolonged activated partial thromboplastin time in plasma samples
    Shimonishi, Naruto
    Ogiwara, Kenichi
    Onishi, Kengo
    Kawabe, Toshiki
    Nishio, Tomohisa
    Nogami, Keiji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2025, 121 (02) : 151 - 160
  • [10] Activated partial thromboplastin time-based clot waveform analysis enables measurement of very low levels of factor IX activity in patients with severe hemophilia B
    Atsuko Nishiyama
    Kenichi Ogiwara
    Kuniyoshi Mizumachi
    Naoki Hashimoto
    Masahiro Takeyama
    Keiji Nogami
    International Journal of Hematology, 2022, 116 : 778 - 786
12